SIBO and histamine intolerance can share digestive symptoms, including bloating, abdominal discomfort and changes in bowel habits. Some gut bacteria can produce histamine, which makes a connection biologically plausible. But human studies have not established that small intestinal bacterial overgrowth (SIBO) causes histamine intolerance.
The available microbiome findings do not diagnose SIBO, and symptoms alone cannot confirm either condition.
What is SIBO, and what symptoms does it cause?
SIBO describes an excessive number of bacteria in the small intestine, although the definition and methods used to measure it have limitations. It can be associated with gas, bloating, abdominal discomfort and diarrhea. In some patients, especially those with significant underlying intestinal problems, it can also contribute to malabsorption or nutritional deficiencies.
These symptoms are not unique to SIBO. Irritable bowel syndrome (IBS), celiac disease and other gastrointestinal conditions can produce a similar picture. The American Gastroenterological Association’s clinical update emphasizes that no single symptom pattern reliably establishes SIBO.
Can SIBO cause histamine intolerance?
A direct cause-and-effect relationship has not been demonstrated. The hypothesis rests partly on two facts: certain intestinal bacteria can generate histamine, and diamine oxidase (DAO) helps break down dietary histamine in the gut. Neither fact shows that a person with SIBO has excess histamine or will develop histamine intolerance.
Histamine intolerance is also difficult to define and confirm with a single test. Our guide to what causes histamine intolerance discusses the wider range of proposed contributors without treating SIBO as an established root cause.
What gut microbiome studies actually show
A small cross-sectional study compared stool samples from 12 people described as having histamine intolerance and 14 healthy controls. The groups differed in some bacteria associated with histamine production. This suggests an area worth investigating, but does not establish why the differences occurred or whether they caused symptoms.
Stool microbiome findings are not SIBO findings. Stool testing mainly reflects the large-intestinal microbial community. The researchers did not demonstrate bacterial overgrowth in participants’ small intestines. The results therefore cannot prove that those participants had SIBO, that SIBO increased histamine exposure, or that SIBO was responsible for their reactions.
A separate five-person pilot study examined stool microbiome changes during a low-histamine diet combined with DAO supplementation. It had no untreated comparison group and did not test a SIBO treatment. The changes observed cannot show that diet or DAO eradicates bacterial overgrowth or cures histamine intolerance.
Does SIBO lower DAO levels?
That specific mechanism has not been established in humans. DAO is produced mainly by specialized cells in the intestinal lining, where it helps process histamine from food. A review of DAO and gastrointestinal diseases describes this physiology, but it does not demonstrate that SIBO routinely destroys DAO-producing cells or predictably lowers intestinal DAO activity.
Statements that SIBO “wipes out” DAO or continually floods the bloodstream with histamine are stronger than the available evidence. For the enzyme’s established functions and the limits of DAO testing, see DAO enzyme and histamine.
Why symptoms cannot reliably distinguish them
They can share digestive complaints, but symptoms cannot reliably separate them. Bloating, pain, nausea and diarrhea are nonspecific. Flushing, headaches or hives may be reported alongside suspected food-histamine reactions, yet these are not proof of histamine intolerance and do not identify SIBO as the cause.
The timing of symptoms, any reproducible food association, medication use, other diagnoses and signs of malabsorption may help a clinician decide what to investigate. A symptom list, by itself, is not a diagnostic test.
What can SIBO breath tests and DAO blood tests tell you?
Hydrogen and methane breath testing are commonly used when SIBO or related intestinal overgrowth is suspected. The American College of Gastroenterology guideline conditionally suggests testing in selected symptomatic patients, but the certainty of supporting evidence is very low. A 2024 expert appraisal and a 2026 critical review discuss important limitations, including false results and the influence of intestinal transit time.
That does not mean every breath test is useless. It means the result must be interpreted alongside symptoms, risk factors and other possible explanations rather than treated as a final answer on its own.
Histamine intolerance presents a separate diagnostic challenge. There is no single validated test that confirms adverse reactions to ingested histamine, and a serum DAO result alone is not diagnostic. The multisociety clinical guidance recommends a careful differential evaluation rather than assuming a laboratory value explains all food-related symptoms.
Does treating SIBO resolve histamine intolerance?
There is no reliable human evidence that treating SIBO consistently resolves histamine intolerance. A person with appropriately evaluated SIBO may receive treatment for that condition and experience digestive symptom improvement. Such improvement would not by itself prove that SIBO had caused a separate histamine-intolerance disorder.
No study reviewed for this article tested SIBO eradication as a validated treatment for histamine intolerance. Antibiotic regimens, herbal antimicrobials and probiotic products should not be presented as an established treatment for both conditions.
Do you need both a low-FODMAP and a low-histamine diet?
Not routinely. Combining two restrictive diets can make meals unnecessarily complicated and may reduce nutritional variety. Evidence for dietary treatment of histamine intolerance is still limited, as discussed in a 2025 review whose author affiliations include a DAO-ingredient manufacturer.
A low-FODMAP diet may ease symptoms for some people with IBS, but evidence from IBS cannot be assumed to prove that it treats SIBO. The AGA’s patient guidance distinguishes symptom management from curing overgrowth.
If dietary restriction is considered, a gastrointestinal dietitian can help keep it time-limited, nutritionally adequate and followed by reintroduction. Our histamine intolerance treatment guide covers the broader evidence without prescribing a combined elimination diet.
What should you do if both conditions are suspected?
Start with a clinician’s review of your digestive history, food-reaction pattern, medical conditions and medications. Discuss whether testing for SIBO is appropriate and whether other causes, such as IBS, celiac disease or a food allergy, need assessment. A short record of symptoms, meals and their timing can help describe patterns, but it cannot diagnose either condition.
Seek prompt medical care for severe or persistent abdominal pain, blood in the stool, repeated vomiting or unexplained weight loss. Breathing difficulty, throat swelling or fainting during a reaction require emergency care. If food allergy is suspected, do not attempt an unsupervised food challenge.
Bottom line
Gut bacteria may influence histamine biology, and some digestive symptoms overlap. What remains unproven is that SIBO causes histamine intolerance or that treating SIBO cures it. Interpreting symptoms and tests in context is more useful than assuming both diagnoses from an online checklist.
References
- Shah A, Holtmann G, Gibson PR. Critical Review: The Past, Present, and Future of Small Intestinal Bacterial Overgrowth (SIBO). JGH Open. 2026;10(5):e70419. doi:10.1002/jgh3.70419. PMID:42146105.
- Kashyap P, Moayyedi P, Quigley EMM, Simrén M, Vanner S. Critical appraisal of the SIBO hypothesis and breath testing: A clinical practice update endorsed by the European society of neurogastroenterology and motility (ESNM) and the American neurogastroenterology and motility society (ANMS). Neurogastroenterol Motil. 2024;36(6):e14817. doi:10.1111/nmo.14817. PMID:38798120.
- Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2020;115(2):165–178. doi:10.14309/ajg.0000000000000501. PMID:32023228.
- Quigley EMM, Murray JA, Pimentel M. AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review. Gastroenterology. 2020;159(4):1526–1532. doi:10.1053/j.gastro.2020.06.090. PMID:32679220.
- Sánchez-Pérez S, Comas-Basté O, Duelo A, et al. Intestinal Dysbiosis in Patients with Histamine Intolerance. Nutrients. 2022;14(9):1774. doi:10.3390/nu14091774. PMID:35565742.
- Sánchez-Pérez S, Comas-Basté O, Duelo A, et al. The dietary treatment of histamine intolerance reduces the abundance of some histamine-secreting bacteria of the gut microbiota in histamine intolerant women. A pilot study. Front Nutr. 2022;9:1018463. doi:10.3389/fnut.2022.1018463. PMID:36337620.
- Reese I, Ballmer-Weber B, Beyer K, et al. Guideline on management of suspected adverse reactions to ingested histamine. Allergol Select. 2021;5:305–314. doi:10.5414/ALX02269E. PMID:34651098.
- Jackson K, Busse W, Gálvez-Martín P, et al. Evidence for Dietary Management of Histamine Intolerance. Int J Mol Sci. 2025;26(18):9198. doi:10.3390/ijms26189198. PMID:41009760.
- Żybul P, Przybyłkowski A, Wojas O, Samoliński B. Diamine Oxidase and Gastrointestinal Diseases. Biomolecules. 2026;16(8):1136. doi:10.3390/biom16081136. PMID:42650803.
- American Gastroenterological Association. Small intestinal bacterial overgrowth (SIBO): Managing with diet. AGA GI Patient Center. Accessed 2026 Oct 26.
